Market Intelligence chevron_right Medical Care chevron_right Recombinant Plasma Proteins
Global Report 2022

Global Recombinant Plasma Proteins Market Research Report 2023

calendar_todayPublished: Jun 2022 descriptionPages: 81 categoryCategory: Medical Care
cloud_downloadRequest Sample Report
mailPre-Order Enquiry
local_offerGet Discount 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Recombinant Plasma Proteins Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Chinese Hamster Ovary (CHO) Cell Line
        1.2.3 Baby Hamster Kidney (BHK) Cell Line
        1.2.4 Human Embryonic Kidney (HEK) Cell Line
        1.2.5 Others
    1.3 Market by Application
        1.3.1 Global Recombinant Plasma Proteins Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hemophilia A
        1.3.3 Hemophilia B
        1.3.4 Von Willebrand Disease
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Recombinant Plasma Proteins Market Perspective (2017-2028)
    2.2 Recombinant Plasma Proteins Growth Trends by Region
        2.2.1 Recombinant Plasma Proteins Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Recombinant Plasma Proteins Historic Market Size by Region (2017-2022)
        2.2.3 Recombinant Plasma Proteins Forecasted Market Size by Region (2023-2028)
    2.3 Recombinant Plasma Proteins Market Dynamics
        2.3.1 Recombinant Plasma Proteins Industry Trends
        2.3.2 Recombinant Plasma Proteins Market Drivers
        2.3.3 Recombinant Plasma Proteins Market Challenges
        2.3.4 Recombinant Plasma Proteins Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Recombinant Plasma Proteins Players by Revenue
        3.1.1 Global Top Recombinant Plasma Proteins Players by Revenue (2017-2022)
        3.1.2 Global Recombinant Plasma Proteins Revenue Market Share by Players (2017-2022)
    3.2 Global Recombinant Plasma Proteins Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Recombinant Plasma Proteins Revenue
    3.4 Global Recombinant Plasma Proteins Market Concentration Ratio
        3.4.1 Global Recombinant Plasma Proteins Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Recombinant Plasma Proteins Revenue in 2021
    3.5 Recombinant Plasma Proteins Key Players Head office and Area Served
    3.6 Key Players Recombinant Plasma Proteins Product Solution and Service
    3.7 Date of Enter into Recombinant Plasma Proteins Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Recombinant Plasma Proteins Breakdown Data by Type
    4.1 Global Recombinant Plasma Proteins Historic Market Size by Type (2017-2022)
    4.2 Global Recombinant Plasma Proteins Forecasted Market Size by Type (2023-2028)
5 Recombinant Plasma Proteins Breakdown Data by Application
    5.1 Global Recombinant Plasma Proteins Historic Market Size by Application (2017-2022)
    5.2 Global Recombinant Plasma Proteins Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Recombinant Plasma Proteins Market Size (2017-2028)
    6.2 North America Recombinant Plasma Proteins Market Size by Country (2017-2022)
    6.3 North America Recombinant Plasma Proteins Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Recombinant Plasma Proteins Market Size (2017-2028)
    7.2 Europe Recombinant Plasma Proteins Market Size by Country (2017-2022)
    7.3 Europe Recombinant Plasma Proteins Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Recombinant Plasma Proteins Market Size (2017-2028)
    8.2 Asia-Pacific Recombinant Plasma Proteins Market Size by Country (2017-2022)
    8.3 Asia-Pacific Recombinant Plasma Proteins Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Recombinant Plasma Proteins Market Size (2017-2028)
    9.2 Latin America Recombinant Plasma Proteins Market Size by Country (2017-2022)
    9.3 Latin America Recombinant Plasma Proteins Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Recombinant Plasma Proteins Market Size (2017-2028)
    10.2 Middle East & Africa Recombinant Plasma Proteins Market Size by Country (2017-2022)
    10.3 Middle East & Africa Recombinant Plasma Proteins Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 CSL Limited
        11.1.1 CSL Limited Company Detail
        11.1.2 CSL Limited Business Overview
        11.1.3 CSL Limited Recombinant Plasma Proteins Introduction
        11.1.4 CSL Limited Revenue in Recombinant Plasma Proteins Business (2017-2022)
        11.1.5 CSL Limited Recent Development
    11.2 Shire (Takeda Pharmaceutical Company Limited)
        11.2.1 Shire (Takeda Pharmaceutical Company Limited) Company Detail
        11.2.2 Shire (Takeda Pharmaceutical Company Limited) Business Overview
        11.2.3 Shire (Takeda Pharmaceutical Company Limited) Recombinant Plasma Proteins Introduction
        11.2.4 Shire (Takeda Pharmaceutical Company Limited) Revenue in Recombinant Plasma Proteins Business (2017-2022)
        11.2.5 Shire (Takeda Pharmaceutical Company Limited) Recent Development
    11.3 Octapharma
        11.3.1 Octapharma Company Detail
        11.3.2 Octapharma Business Overview
        11.3.3 Octapharma Recombinant Plasma Proteins Introduction
        11.3.4 Octapharma Revenue in Recombinant Plasma Proteins Business (2017-2022)
        11.3.5 Octapharma Recent Development
    11.4 Novo Nordisk
        11.4.1 Novo Nordisk Company Detail
        11.4.2 Novo Nordisk Business Overview
        11.4.3 Novo Nordisk Recombinant Plasma Proteins Introduction
        11.4.4 Novo Nordisk Revenue in Recombinant Plasma Proteins Business (2017-2022)
        11.4.5 Novo Nordisk Recent Development
    11.5 Bayer
        11.5.1 Bayer Company Detail
        11.5.2 Bayer Business Overview
        11.5.3 Bayer Recombinant Plasma Proteins Introduction
        11.5.4 Bayer Revenue in Recombinant Plasma Proteins Business (2017-2022)
        11.5.5 Bayer Recent Development
    11.6 Bioverativ Therapeutics, Inc. (Sanofi)
        11.6.1 Bioverativ Therapeutics, Inc. (Sanofi) Company Detail
        11.6.2 Bioverativ Therapeutics, Inc. (Sanofi) Business Overview
        11.6.3 Bioverativ Therapeutics, Inc. (Sanofi) Recombinant Plasma Proteins Introduction
        11.6.4 Bioverativ Therapeutics, Inc. (Sanofi) Revenue in Recombinant Plasma Proteins Business (2017-2022)
        11.6.5 Bioverativ Therapeutics, Inc. (Sanofi) Recent Development
    11.7 Aptevo Therapeutics
        11.7.1 Aptevo Therapeutics Company Detail
        11.7.2 Aptevo Therapeutics Business Overview
        11.7.3 Aptevo Therapeutics Recombinant Plasma Proteins Introduction
        11.7.4 Aptevo Therapeutics Revenue in Recombinant Plasma Proteins Business (2017-2022)
        11.7.5 Aptevo Therapeutics Recent Development
    11.8 Pharming Group
        11.8.1 Pharming Group Company Detail
        11.8.2 Pharming Group Business Overview
        11.8.3 Pharming Group Recombinant Plasma Proteins Introduction
        11.8.4 Pharming Group Revenue in Recombinant Plasma Proteins Business (2017-2022)
        11.8.5 Pharming Group Recent Development
    11.9 Pfizer
        11.9.1 Pfizer Company Detail
        11.9.2 Pfizer Business Overview
        11.9.3 Pfizer Recombinant Plasma Proteins Introduction
        11.9.4 Pfizer Revenue in Recombinant Plasma Proteins Business (2017-2022)
        11.9.5 Pfizer Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Recombinant Plasma Proteins Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Chinese Hamster Ovary (CHO) Cell Line
    Table 3. Key Players of Baby Hamster Kidney (BHK) Cell Line
    Table 4. Key Players of Human Embryonic Kidney (HEK) Cell Line
    Table 5. Key Players of Others
    Table 6. Global Recombinant Plasma Proteins Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Recombinant Plasma Proteins Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Recombinant Plasma Proteins Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Recombinant Plasma Proteins Market Share by Region (2017-2022)
    Table 10. Global Recombinant Plasma Proteins Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Recombinant Plasma Proteins Market Share by Region (2023-2028)
    Table 12. Recombinant Plasma Proteins Market Trends
    Table 13. Recombinant Plasma Proteins Market Drivers
    Table 14. Recombinant Plasma Proteins Market Challenges
    Table 15. Recombinant Plasma Proteins Market Restraints
    Table 16. Global Recombinant Plasma Proteins Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Recombinant Plasma Proteins Market Share by Players (2017-2022)
    Table 18. Global Top Recombinant Plasma Proteins Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Plasma Proteins as of 2021)
    Table 19. Ranking of Global Top Recombinant Plasma Proteins Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Recombinant Plasma Proteins Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Recombinant Plasma Proteins Product Solution and Service
    Table 23. Date of Enter into Recombinant Plasma Proteins Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Recombinant Plasma Proteins Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Recombinant Plasma Proteins Revenue Market Share by Type (2017-2022)
    Table 27. Global Recombinant Plasma Proteins Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Recombinant Plasma Proteins Revenue Market Share by Type (2023-2028)
    Table 29. Global Recombinant Plasma Proteins Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Recombinant Plasma Proteins Revenue Market Share by Application (2017-2022)
    Table 31. Global Recombinant Plasma Proteins Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Recombinant Plasma Proteins Revenue Market Share by Application (2023-2028)
    Table 33. North America Recombinant Plasma Proteins Market Size by Country (2017-2022) & (US$ Million)
    Table 34. North America Recombinant Plasma Proteins Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Europe Recombinant Plasma Proteins Market Size by Country (2017-2022) & (US$ Million)
    Table 36. Europe Recombinant Plasma Proteins Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Asia-Pacific Recombinant Plasma Proteins Market Size by Region (2017-2022) & (US$ Million)
    Table 38. Asia-Pacific Recombinant Plasma Proteins Market Size by Region (2023-2028) & (US$ Million)
    Table 39. Latin America Recombinant Plasma Proteins Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Latin America Recombinant Plasma Proteins Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Middle East & Africa Recombinant Plasma Proteins Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Middle East & Africa Recombinant Plasma Proteins Market Size by Country (2023-2028) & (US$ Million)
    Table 43. CSL Limited Company Detail
    Table 44. CSL Limited Business Overview
    Table 45. CSL Limited Recombinant Plasma Proteins Product
    Table 46. CSL Limited Revenue in Recombinant Plasma Proteins Business (2017-2022) & (US$ Million)
    Table 47. CSL Limited Recent Development
    Table 48. Shire (Takeda Pharmaceutical Company Limited) Company Detail
    Table 49. Shire (Takeda Pharmaceutical Company Limited) Business Overview
    Table 50. Shire (Takeda Pharmaceutical Company Limited) Recombinant Plasma Proteins Product
    Table 51. Shire (Takeda Pharmaceutical Company Limited) Revenue in Recombinant Plasma Proteins Business (2017-2022) & (US$ Million)
    Table 52. Shire (Takeda Pharmaceutical Company Limited) Recent Development
    Table 53. Octapharma Company Detail
    Table 54. Octapharma Business Overview
    Table 55. Octapharma Recombinant Plasma Proteins Product
    Table 56. Octapharma Revenue in Recombinant Plasma Proteins Business (2017-2022) & (US$ Million)
    Table 57. Octapharma Recent Development
    Table 58. Novo Nordisk Company Detail
    Table 59. Novo Nordisk Business Overview
    Table 60. Novo Nordisk Recombinant Plasma Proteins Product
    Table 61. Novo Nordisk Revenue in Recombinant Plasma Proteins Business (2017-2022) & (US$ Million)
    Table 62. Novo Nordisk Recent Development
    Table 63. Bayer Company Detail
    Table 64. Bayer Business Overview
    Table 65. Bayer Recombinant Plasma Proteins Product
    Table 66. Bayer Revenue in Recombinant Plasma Proteins Business (2017-2022) & (US$ Million)
    Table 67. Bayer Recent Development
    Table 68. Bioverativ Therapeutics, Inc. (Sanofi) Company Detail
    Table 69. Bioverativ Therapeutics, Inc. (Sanofi) Business Overview
    Table 70. Bioverativ Therapeutics, Inc. (Sanofi) Recombinant Plasma Proteins Product
    Table 71. Bioverativ Therapeutics, Inc. (Sanofi) Revenue in Recombinant Plasma Proteins Business (2017-2022) & (US$ Million)
    Table 72. Bioverativ Therapeutics, Inc. (Sanofi) Recent Development
    Table 73. Aptevo Therapeutics Company Detail
    Table 74. Aptevo Therapeutics Business Overview
    Table 75. Aptevo Therapeutics Recombinant Plasma Proteins Product
    Table 76. Aptevo Therapeutics Revenue in Recombinant Plasma Proteins Business (2017-2022) & (US$ Million)
    Table 77. Aptevo Therapeutics Recent Development
    Table 78. Pharming Group Company Detail
    Table 79. Pharming Group Business Overview
    Table 80. Pharming Group Recombinant Plasma Proteins Product
    Table 81. Pharming Group Revenue in Recombinant Plasma Proteins Business (2017-2022) & (US$ Million)
    Table 82. Pharming Group Recent Development
    Table 83. Pfizer Company Detail
    Table 84. Pfizer Business Overview
    Table 85. Pfizer Recombinant Plasma Proteins Product
    Table 86. Pfizer Revenue in Recombinant Plasma Proteins Business (2017-2022) & (US$ Million)
    Table 87. Pfizer Recent Development
    Table 88. Research Programs/Design for This Report
    Table 89. Key Data Information from Secondary Sources
    Table 90. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Recombinant Plasma Proteins Market Share by Type: 2021 VS 2028
    Figure 2. Chinese Hamster Ovary (CHO) Cell Line Features
    Figure 3. Baby Hamster Kidney (BHK) Cell Line Features
    Figure 4. Human Embryonic Kidney (HEK) Cell Line Features
    Figure 5. Others Features
    Figure 6. Global Recombinant Plasma Proteins Market Share by Application in 2021 & 2028
    Figure 7. Hemophilia A Case Studies
    Figure 8. Hemophilia B Case Studies
    Figure 9. Von Willebrand Disease Case Studies
    Figure 10. Others Case Studies
    Figure 11. Recombinant Plasma Proteins Report Years Considered
    Figure 12. Global Recombinant Plasma Proteins Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 13. Global Recombinant Plasma Proteins Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Recombinant Plasma Proteins Market Share by Region: 2021 VS 2028
    Figure 15. Global Recombinant Plasma Proteins Market Share by Players in 2021
    Figure 16. Global Top Recombinant Plasma Proteins Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Plasma Proteins as of 2021)
    Figure 17. The Top 10 and 5 Players Market Share by Recombinant Plasma Proteins Revenue in 2021
    Figure 18. North America Recombinant Plasma Proteins Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. North America Recombinant Plasma Proteins Market Share by Country (2017-2028)
    Figure 20. United States Recombinant Plasma Proteins Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Canada Recombinant Plasma Proteins Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Recombinant Plasma Proteins Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Recombinant Plasma Proteins Market Share by Country (2017-2028)
    Figure 24. Germany Recombinant Plasma Proteins Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. France Recombinant Plasma Proteins Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. U.K. Recombinant Plasma Proteins Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Italy Recombinant Plasma Proteins Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Russia Recombinant Plasma Proteins Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Nordic Countries Recombinant Plasma Proteins Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Recombinant Plasma Proteins Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Recombinant Plasma Proteins Market Share by Region (2017-2028)
    Figure 32. China Recombinant Plasma Proteins Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Japan Recombinant Plasma Proteins Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. South Korea Recombinant Plasma Proteins Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Southeast Asia Recombinant Plasma Proteins Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. India Recombinant Plasma Proteins Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Australia Recombinant Plasma Proteins Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Recombinant Plasma Proteins Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Latin America Recombinant Plasma Proteins Market Share by Country (2017-2028)
    Figure 40. Mexico Recombinant Plasma Proteins Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Brazil Recombinant Plasma Proteins Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Recombinant Plasma Proteins Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Middle East & Africa Recombinant Plasma Proteins Market Share by Country (2017-2028)
    Figure 44. Turkey Recombinant Plasma Proteins Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Saudi Arabia Recombinant Plasma Proteins Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. CSL Limited Revenue Growth Rate in Recombinant Plasma Proteins Business (2017-2022)
    Figure 47. Shire (Takeda Pharmaceutical Company Limited) Revenue Growth Rate in Recombinant Plasma Proteins Business (2017-2022)
    Figure 48. Octapharma Revenue Growth Rate in Recombinant Plasma Proteins Business (2017-2022)
    Figure 49. Novo Nordisk Revenue Growth Rate in Recombinant Plasma Proteins Business (2017-2022)
    Figure 50. Bayer Revenue Growth Rate in Recombinant Plasma Proteins Business (2017-2022)
    Figure 51. Bioverativ Therapeutics, Inc. (Sanofi) Revenue Growth Rate in Recombinant Plasma Proteins Business (2017-2022)
    Figure 52. Aptevo Therapeutics Revenue Growth Rate in Recombinant Plasma Proteins Business (2017-2022)
    Figure 53. Pharming Group Revenue Growth Rate in Recombinant Plasma Proteins Business (2017-2022)
    Figure 54. Pfizer Revenue Growth Rate in Recombinant Plasma Proteins Business (2017-2022)
    Figure 55. Bottom-up and Top-down Approaches for This Report
    Figure 56. Data Triangulation
    Figure 57. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
CSL Limited
Shire (Takeda Pharmaceutical Company Limited)
Octapharma
Novo Nordisk
Bayer
Bioverativ Therapeutics, Inc. (Sanofi)
Aptevo Therapeutics
Pharming Group
Pfizer

Frequently Asked Questions

What is the USP of the report? expand_more
Recombinant Plasma Proteins report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
What are the key content of the report? expand_more
Recombinant Plasma Proteins report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
What are the value propositions and opportunities offered in this market research report? expand_more
Recombinant Plasma Proteins report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.